Preprint · CC0
via OpenAlex
Senolytic therapy targeting CDKN2A/TP53/SASP pathway with dasatinib-quercetin
MedicOath Autonomous Discovery Engine
Zenodo (CERN European Organization for Nuclear Research) · 2026
Abstract
Selective elimination of senescent vascular smooth muscle cells expressing high CDKN2A (p16) and TP53. Reduces senescence(definition)-associated secretory phenotype (SASP) factors including IL6, TNF-α, and MMPs that contribute to aortic wall degradation in familial predisposition.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5281/zenodo.19832687
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Engine, M.A.D. (2026). Senolytic therapy targeting CDKN2A/TP53/SASP pathway with dasatinib-quercetin. <em>Zenodo (CERN European Organization for Nuclear Research)</em>. https://doi.org/10.5281/zenodo.19832687
Vancouver
Engine MAD. Senolytic therapy targeting CDKN2A/TP53/SASP pathway with dasatinib-quercetin. Zenodo (CERN European Organization for Nuclear Research). 2026. doi:10.5281/zenodo.19832687.
BibTeX
@unpublished{medicoath2026Senoly,
title = {Senolytic therapy targeting CDKN2A/TP53/SASP pathway with dasatinib-quercetin},
author = {MedicOath Autonomous Discovery Engine},
journal = {Zenodo (CERN European Organization for Nuclear Research)},
year = {2026},
doi = {10.5281/zenodo.19832687},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ageing Research Reviews 2025
Citation only
Apheresis for senescence: Targeting the senescence-associated secretory phenotype to delay aging and age-related diseases
Aging 2026
Open access · CC-BY
Small extracellular vesicles as mediators of paracrine senescence in cellular models of aging
Frontiers in endocrinology 2026
Open access · OA
The aging secretome as a candidate driver of bone remodeling imbalance: myokines, adipokines, and senescence-associated secretory factors.
Journal of Biological Chemistry 2011
Open access · CC-BY
Tumor Suppressor and Aging Biomarker p16INK4a Induces Cellular Senescence without the Associated Inflammatory Secretory Phenotype
Elsevier eBooks 2021
Citation only
Cellular senescence and senescence-associated secretory phenotype (SASP) in aging process
The Journal of Biochemistry 2019
Citation only